Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Lewin

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|April 8, 2011
A Dose-Ranging Study of the DPP-IV Inhibitor PF-734200 Added to Metformin in Subjects With Type 2 Diabetes*S G Terra, V Somayaji, S Schwartz, et al.
Artificial Organs|August 1, 1979
Applications of the Redy sorbent system to hemodialysis and peritoneal dialysisM J Blumenkrantz, A Gordon, M Roberts, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 12, 2011
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetesJ Rosenstock, A J Lewin, P Norwood, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertensionJ L Pool, J Gennari, R Goldstein, et al.
Archives of Internal Medicine|December 31, 1997
There are no racial, age, sex, or weight differences in the effect of salt on blood pressure in salt-sensitive hypertensive patientsS G Chrysant, M R Weir, A B Weder, et al.
American Journal of Hypertension|March 1, 1992
A comparison of the safety of therapeutically equivalent doses of isradipine and diltiazem for treatment of essential hypertensionH R Black, A J Lewin, G H Stein, et al.
Hypertension (Dallas, Tex. : 1979)|May 12, 1998
Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensivesM R Weir, S G Chrysant, D A McCarron, et al.
American Journal of Hypertension|November 15, 2000
Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial InvestigatorsS G Chrysant, A B Weder, D A McCarron, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|April 8, 2011
A Dose-Ranging Study of the DPP-IV Inhibitor PF-734200 Added to Metformin in Subjects With Type 2 Diabetes*S G Terra, V Somayaji, S Schwartz, et al.
Artificial Organs|August 1, 1979
Applications of the Redy sorbent system to hemodialysis and peritoneal dialysisM J Blumenkrantz, A Gordon, M Roberts, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 12, 2011
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetesJ Rosenstock, A J Lewin, P Norwood, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertensionJ L Pool, J Gennari, R Goldstein, et al.
Archives of Internal Medicine|December 31, 1997
There are no racial, age, sex, or weight differences in the effect of salt on blood pressure in salt-sensitive hypertensive patientsS G Chrysant, M R Weir, A B Weder, et al.
American Journal of Hypertension|March 1, 1992
A comparison of the safety of therapeutically equivalent doses of isradipine and diltiazem for treatment of essential hypertensionH R Black, A J Lewin, G H Stein, et al.
Hypertension (Dallas, Tex. : 1979)|May 12, 1998
Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensivesM R Weir, S G Chrysant, D A McCarron, et al.
American Journal of Hypertension|November 15, 2000
Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial InvestigatorsS G Chrysant, A B Weder, D A McCarron, et al.
Pageof 2